Showing results (41-50 of 433) with videos related to

Sort By:
Pageof 44
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|April 3, 2013
Quantifying tumour heterogeneity with CTBalaji Ganeshan, Kenneth A Miles
Hematology/Oncology Clinics of North America|November 18, 2008
Role of functional imaging in head and neck squamous cell carcinoma: fluorodeoxyglucose positron emission tomography and beyondSandro V Porceddu, Bryan H Burmeister, Rodney J Hicks
Clinical Nuclear Medicine|July 13, 2012
Scatter limitation to correct for arm movement in PET/CTJason Callahan, David Binns, Timothy Deller, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|September 4, 2007
Overview of early response assessment in lymphoma with FDG-PETMichael P MacManus, John F Seymour, Rodney J Hicks
Journal of Medical Imaging and Radiation Oncology|March 9, 2011
Imaging, radiation oncology and randomised trials: time for a change?Gillian M Duchesne, Shih-Chang Wang, Rodney J Hicks
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2009
Cost-effectiveness of 99mTc-sestamibi in predicting response to chemotherapy in patients with lung cancer: systematic review and meta-analysisHosahalli K Mohan, Kenneth A Miles
Radiology|July 27, 2010
Multiparametric imaging of tumor response to therapyAnwar R Padhani, Kenneth A Miles
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|September 25, 2013
Incorporating prognostic imaging biomarkers into clinical practiceW Phillip Law, Kenneth A Miles
Radiographics : a Review Publication of the Radiological Society of North America, Inc|January 11, 2018
Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and PitfallsMichael S Hofman, Rodney J Hicks, Tobias Maurer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2012
18F-FDG PET as a surrogate biomarker in non-small cell lung cancer treated with erlotinib: newly identified lesions are more informative than standardized uptake valueThomas Bengtsson, Rodney J Hicks, Amy Peterson, et al.
Pageof 44